16/04/2026
Our Representation Layer Extends to a New Domain: 8 Therapies
Alphabiome extends its reference-free intelligence layer to a new domain, turning raw genetic signal into response prediction across three indications and 8 therapies.
The first AI
representation layer for the
unknown genetic universe
Alphabiome learns directly from raw DNA and RNA sequencing data- without reference genomes, predefined features or known biological annotations.
AI can only learn from biology it can represent
Most biological AI begins after humans have already mapped the sequence to known genes, species, proteins or annotations. Everything outside that map is compressed, discarded or treated as noise.
Alphabiome starts earlier – from the raw genetic signal itself.
Biology has a
hidden vocabulary.
We found it.
Our reference-free engine discovers recurring communities of genetic fragments and organizes them into a global vocabulary of more than 100,000 canonical biological tokens.
These tokens are not predefined genes, species or human annotations. They emerge from structure in the data – and can be reused across organisms, tissues, datasets and questions.
First Application Drug Development
The biological intelligence layer predicts treatment response: which patients are likely to respond, which are not, and why. This turns years of translational research into days of computation and enables trials to run with fewer, better-selected patients, lowering cost and risk across development. Together, these enable precision medicine and better outcomes for patients.
Discover Alphabiome
Learn more about how Alphabiome’s groundbreaking technology is opening new frontiers in precision medicine.
Science & News
06/05/2025
AI That Predicts Drug Response from Raw Genetic Signal
Health Technology Net- Alphabiome’s engine reads raw, unannotated DNA beyond reference genomes, delivering unmatched signal for AI drug-response prediction.
06/05/2025
Alphabiome Unveils Revolutionary AI for Reference-Free Decoding
Alphabiome tokenizes raw genetic sequence that today’s biology AI can’t read, to accurately predict response.
21/11/2025
Peer-Reviewed: Reference-Free AI Validated at Scale
A peer-reviewed study validated Alphabiome’s reference-free AI across 10 farms and 339 animals, predicting response directly from raw DNA signal.
07/05/2025
Alphabiome Raises $8M to Build the Biological AI Layer
Finsmes.com- Alphabiome secures seed funding to expand R&D and build the representation layer between raw genetic signal and biological AI.
04/02/2026
Clinical Study: Our AI Predicts Response Across 7 Biologics
In a leading-hospital study, Alphabiome’s AI predicted response across seven biologic drugs, showing up to 3x higher accuracy than state-of-the-art models.
25/09/2025
Independent Validation: Our Reference-Free AI Predicts Again
A controlled trial validated Alphabiome’s reference-free AI on a second compound- an independent test of the same engine on new raw sequence.
25/11/2025
Predicting Response Straight from Raw DNA Signal
Alphabiome’s reference-free AI now reaches human disease. Our tokenization engine reads raw DNA the rest of biology AI can’t, then predicts response.
10/04/2025
Peer-Reviewed Validation: Cross-Farm Prediction Across 13 Herds
A peer-reviewed study validated Alphabiome’s reference-free AI across 13 commercial dairy herds, predicting additive response directly from raw genetic signal alone.
08/09/2024
From Swarm Math to Biology: Predicting Response from Raw Sequence
Our R&D team carries decentralized swarm mathematics into genomics, predicting feed additive efficacy from rumen sequencing, in CRC Press’s Applied Swarm Intelligence
09/01/2024
The Biological Intelligence Layer for AI
Our white paper sets out the thesis behind Alphabiome, tokenizing raw reference-free DNA into the biological intelligence layer today’s biology AI cannot read.
Our Partners
